Sichuan Kelun-biotech Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Sichuan Kelun-biotech Biopharmaceutical Co., Ltd., explained in plain language.
-
New cancer drug injected directly into tumors shows early promise
Disease control CompletedThis early-stage study tested the safety of an experimental drug called KL340399 when injected directly into tumors. The trial involved 6 patients with advanced solid cancers who had exhausted standard treatment options. Researchers aimed to find the highest safe dose and gather …
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer drug matchup shows promise in major trial
Disease control CompletedThis study compared two different drug combinations for treating advanced colorectal cancer that has spread to other parts of the body. Researchers tested whether a new drug called A140 works as well as an existing drug called Erbitux when both are combined with standard chemothe…
Phase: PHASE3 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cancer drug begins human testing in patients out of options
Disease control CompletedThis first-in-human study tested a new drug called KL340399 injection in 21 patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose, see how the body processes the drug, and check for any early signs that it …
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC